Status and phase
Conditions
Treatments
About
This is a prospective randomized placebo-controlled double-blind crossover study determining the effect of dichloroacetate on brain glucose metabolism under clamped hypoglycemia in T1DM.
Full description
This study is a prospective randomized placebo-controlled double-blind crossover study designed to address the hypothesis that dichloroacetate has the ability to re-activate brain glucose metabolism under clamped hypoglycemia. The study population is comprised of intensively treated persons with T1D with frequent exposure to hypoglycemia, who have cognitive deficits under hypoglycemia that could be attributed to changes in brain glucose oxidation. The investigators will test the experimental compound DCA in a mechanistic study that determines whether brain metabolism is restored by this intervention, or whether the drug effect was primarily caused by changes in physiology outside of the brain.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
T1DM subjects with:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
16 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Alice Hahn
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal